arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

National Vision Holdings, Inc.

EYE Health Care Ophthalmic Goods
$18.87
▲ +5.1% Today
as of Oct 22, 16:48 ET
Last 30 days +7.77% Sep 14 → Oct 22
$15.61 $16.48 $17.36 $18.24 $19.11 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$17.79
High
$18.87
Low
$17.77
Volume
$1M
Avg Vol
$2M
Mkt Cap
$1.3B
P/E (TTM)
30.58
Beta
—
52w High
$30.02
52w Low
$14.75
Div Yield
—
Shares Out
$79M

Recent Press Releases & News last 60 days · 9 items

Oct 12 · 12:04 PR Business Wire
National Vision Launches 2026-2027 Scholarship Program, Exploring the Balance Between Innovation and Human Connection
Sep 28 · 14:40 Zacks
EYE or CL: Which Is the Better Value Stock Right Now?
Sep 23 · 19:50 Investing.com
Exclusive: National Vision CEO on traffic, ticket growth and the digital shift
▸ Show all 9 press releases & news Free account →

EYE earnings at a glance

National Vision Holdings, Inc. (EYE) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of $0.06, compared with $0.07 in the same quarter last year (-14%). The options market is pricing a move of about ±11.1% after the report, a range of roughly $16.78 to $20.96 from today's $18.87. Over its last 6 reports the stock rose the next day 2 times and fell 4, moving ±10.7% on average; after the most recent report on Aug 12, 2026 it moved -11.6%. That means options currently expect about the same movement than EYE has typically delivered. EYE beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 94%. The share price of $18.87 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$15
$30
27% of range
Avg surprise (last 6)
+196.0%
Avg reaction (last 6)
-2.0%
33% positive
Latest IV / EM
94%
EM ±11.1% · $18 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.11$0.02$0.15$0.27$0.40 Actual $0.15Actual $-0.04Actual $-0.11Actual $0.27Est $0.24Actual $0.13Est $0.06Actual $0.07Est $0.05Actual $0.08Est $-0.01Actual $0.40Est $0.34Actual $0.17Est $0.09 MarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-8M$136M$281M$426M$571M Sep 24Mar 25Jun 25Sep 25Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Aug 12, 2026Jun/2026 $0.17 $0.09 +88.9% -30.8% -11.6% earnings
Wed May 13, 2026Mar/2026 $0.40 $0.34 +17.6% +48.1% -19.2% earnings
Wed Mar 4, 20268K 2026-03-04 $0.08 $-0.01 +900.0% — +9.1% earnings
Wed Nov 5, 2025Sep/2025 $0.07 $0.05 +40.0% — -3.5% earnings
Wed Aug 6, 2025Jun/2025 $0.13 $0.06 +116.7% — -3.7% earnings
Wed May 7, 2025Mar/2025 $0.27 $0.24 +12.5% — +17.1% earnings
Sat Sep 28, 2024Sep 2024 $-0.11 — — — — financials
Sat Jun 29, 2024Jun 2024 $-0.04 — — — — financials
Sat Mar 30, 2024Mar 2024 $0.15 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER $0.06$0.07 -14.3%

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Jan 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$499M$544M—$487M$486M$510M—$452M
Cost of revenue————————
Gross profit————————
Operating income$21M$45M—$10M$16M$26M—$-9M
Net income$12M$31M—$3M$9M$14M—$-8M
EPS (diluted)$0.15$0.38—$0.04$0.11$0.18—$-0.11

Balance sheet (quarterly)

MetricJul 2026Apr 2026Jan 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$36M$68M$39M$56M$48M$80M$74M$81M
Inventory$123M$108M$89M$88M$90M$89M$94M$88M
Total current assets$227M$261M$226M$220M$218M$254M$250M$244M
Total assets$1.98B$2.02B$1.98B$1.96B$1.97B$2.01B$2.01B$2.02B
Long-term debt$217M$220M$223M$230M$248M$236M$239M$242M
Total liabilities————————
Total equity$897M$898M$870M$859M$851M$836M$816M$840M

Implied volatility — last 90 days

44%112%180%248%316% Jun 08 — IV 134% · EM ±17.6%Jun 09 — IV 85% · EM ±10.6%Jun 10 — IV 77% · EM ±9.1%Jun 11 — IV 84% · EM ±9.3%Jun 12 — IV 104% · EM ±10.6%Jun 15 — IV 129% · EM ±9.3%Jun 16 — IV 173% · EM ±10.2%Jun 17 — IV 317% · EM ±13.2%Jun 19 — IV 65% · EM ±14.5%Jun 22 — IV 61% · EM ±12.8%Jun 23 — IV 63% · EM ±13.0%Jun 24 — IV 59% · EM ±11.8%Jun 25 — IV 55% · EM ±10.8%Jun 26 — IV 62% · EM ±11.9%Jun 29 — IV 86% · EM ±15.2%Jun 30 — IV 62% · EM ±10.7%Jul 01 — IV 110% · EM ±18.4%Jul 02 — IV 70% · EM ±11.4%Jul 03 — IV 73% · EM ±11.4%Jul 06 — IV 98% · EM ±13.5%Jul 07 — IV 80% · EM ±10.6%Jul 08 — IV 123% · EM ±15.5%Jul 09 — IV 87% · EM ±10.2%Jul 10 — IV 79% · EM ±8.7%Jul 13 — IV 177% · EM ±14.8%Jul 14 — IV 150% · EM ±10.8%Jul 15 — IV 123% · EM ±7.3%Jul 20 — IV 81% · EM ±19.1%Jul 21 — IV 83% · EM ±19.2%Jul 22 — IV 72% · EM ±16.4%Jul 23 — IV 69% · EM ±15.5%Jul 24 — IV 94% · EM ±20.7%Jul 27 — IV 89% · EM ±18.6%Jul 28 — IV 85% · EM ±17.4%Jul 29 — IV 81% · EM ±16.2%Jul 30 — IV 72% · EM ±14.2%Jul 31 — IV 86% · EM ±16.4%Aug 03 — IV 85% · EM ±15.1%Aug 04 — IV 82% · EM ±14.1%Aug 05 — IV 88% · EM ±14.7%Aug 06 — IV 85% · EM ±13.8%Aug 07 — IV 94% · EM ±14.6%Aug 10 — IV 104% · EM ±14.3%Aug 11 — IV 115% · EM ±15.2%Aug 12 — IV 54% · EM ±6.8%Aug 13 — IV 60% · EM ±7.1%Aug 14 — IV 96% · EM ±10.6%Aug 17 — IV 120% · EM ±10.0%Aug 18 — IV 283% · EM ±20.5%Aug 19 — IV 300% · EM ±17.7%Aug 20 — IV 254% · EM ±10.6%Aug 24 — IV 63% · EM ±13.2%Aug 25 — IV 90% · EM ±18.5%Aug 26 — IV 78% · EM ±15.5%Aug 27 — IV 61% · EM ±12.0%Aug 28 — IV 53% · EM ±10.2%Aug 31 — IV 60% · EM ±10.7%Sep 01 — IV 78% · EM ±13.5%Sep 02 — IV 46% · EM ±7.7%Sep 03 — IV 88% · EM ±14.2%Sep 04 — IV 126% · EM ±19.7%Sep 07 — IV 142% · EM ±19.7%Sep 09 — IV 124% · EM ±15.5%Sep 10 — IV 84% · EM ±9.9%Sep 14 — IV 44% · EM ±3.7%Sep 15 — IV 279% · EM ±20.2%Sep 16 — IV 278% · EM ±16.4%Sep 17 — IV 263% · EM ±11.0%Sep 21 — IV 60% · EM ±12.6%Sep 22 — IV 57% · EM ±11.7%Sep 23 — IV 79% · EM ±15.9%Sep 24 — IV 58% · EM ±11.4%Sep 25 — IV 62% · EM ±11.8%Sep 28 — IV 76% · EM ±13.5%Sep 29 — IV 76% · EM ±13.1%Sep 30 — IV 78% · EM ±13.0%Oct 01 — IV 121% · EM ±19.5%Oct 02 — IV 61% · EM ±9.6%Oct 06 — IV 93% · EM ±12.2%Oct 07 — IV 102% · EM ±12.8%Oct 08 — IV 94% · EM ±11.1%

Sector peers

STAA
STAAR Surgical Company
$1.1B $22.49+0.8%
RXST
RxSight, Inc.
$200M $5.08+4.1%
LUCY
Innovative Eyewear, Inc.
$8M $0.86+3.6%
WRBY
Warby Parker Inc.
$3.1B $25.67+0.2%
BLCO
Bausch + Lomb Corporation
$6.2B $17.43+3.0%
COO
The Cooper Companies, Inc.
$13.6B $61.65+4.3%

EYE earnings FAQ

When is EYE's next earnings date?

National Vision Holdings, Inc. is expected to report on November 4, 2026.

What is EYE's expected move for earnings?

Options currently price a move of about ±11.1%, or $2.09 per share either way from $18.87.

How does EYE stock usually react to earnings?

Across the last 6 reports the average next-day move was ±10.7%, up 2 times and down 4 times.

What EPS are analysts expecting from National Vision Holdings, Inc.?

The consensus estimate is $0.06 per share, versus $0.07 a year ago.

What is EYE's implied volatility?

EYE's at-the-money implied volatility is about 94% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in